PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CareDx, Inc (CDNA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS14167L1035
CUSIP14167L103
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$430.28M
EPS-$3.54
PE Ratio82.53
PEG Ratio-0.12
Revenue (TTM)$280.32M
Gross Profit (TTM)$209.58M
EBITDA (TTM)-$89.66M
Year Range$4.80 - $12.93
Target Price$12.40
Short %13.20%
Short Ratio5.03

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CareDx, Inc

Popular comparisons: CDNA vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in CareDx, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%NovemberDecember2024FebruaryMarchApril
67.97%
21.11%
CDNA (CareDx, Inc)
Benchmark (^GSPC)

S&P 500

Returns By Period

CareDx, Inc had a return of -31.42% year-to-date (YTD) and -2.49% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-31.42%6.30%
1 month-13.73%-3.13%
6 months52.13%19.37%
1 year-2.49%22.56%
5 years (annualized)-20.56%11.65%
10 years (annualized)N/A10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-28.67%24.30%-0.47%
2023-24.81%-22.71%79.48%23.58%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of CDNA is 47, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of CDNA is 4747
CareDx, Inc(CDNA)
The Sharpe Ratio Rank of CDNA is 4646Sharpe Ratio Rank
The Sortino Ratio Rank of CDNA is 5050Sortino Ratio Rank
The Omega Ratio Rank of CDNA is 4848Omega Ratio Rank
The Calmar Ratio Rank of CDNA is 4747Calmar Ratio Rank
The Martin Ratio Rank of CDNA is 4646Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for CareDx, Inc (CDNA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


CDNA
Sharpe ratio
The chart of Sharpe ratio for CDNA, currently valued at -0.07, compared to the broader market-2.00-1.000.001.002.003.00-0.07
Sortino ratio
The chart of Sortino ratio for CDNA, currently valued at 0.45, compared to the broader market-4.00-2.000.002.004.006.000.45
Omega ratio
The chart of Omega ratio for CDNA, currently valued at 1.05, compared to the broader market0.501.001.501.05
Calmar ratio
The chart of Calmar ratio for CDNA, currently valued at -0.06, compared to the broader market0.001.002.003.004.005.00-0.06
Martin ratio
The chart of Martin ratio for CDNA, currently valued at -0.22, compared to the broader market0.0010.0020.0030.00-0.22
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-2.00-1.000.001.002.003.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.006.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.001.002.003.004.005.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.007.64

Sharpe Ratio

The current CareDx, Inc Sharpe ratio is -0.07. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.07
1.92
CDNA (CareDx, Inc)
Benchmark (^GSPC)

Dividends

Dividend History


CareDx, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-91.39%
-3.50%
CDNA (CareDx, Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the CareDx, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CareDx, Inc was 94.87%, occurring on Oct 25, 2023. The portfolio has not yet recovered.

The current CareDx, Inc drawdown is 91.39%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.87%Jan 21, 2021696Oct 25, 2023
-92.75%Sep 9, 2014663Apr 27, 2017260May 9, 2018923
-65.22%Jul 12, 2019173Mar 18, 2020137Oct 1, 2020310
-34.25%Mar 22, 201921Apr 22, 201941Jun 19, 201962
-33.74%Dec 4, 201813Dec 21, 201844Feb 27, 201957

Volatility

Volatility Chart

The current CareDx, Inc volatility is 18.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%NovemberDecember2024FebruaryMarchApril
18.26%
3.58%
CDNA (CareDx, Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of CareDx, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items